IRIS Accounts Production v23.4.0.336 09688227 Board of Directors 1.8.22 31.7.23 31.7.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh096882272022-07-31096882272023-07-31096882272022-08-012023-07-31096882272021-07-31096882272021-08-012022-07-31096882272022-07-3109688227ns15:EnglandWales2022-08-012023-07-3109688227ns14:PoundSterling2022-08-012023-07-3109688227ns10:Director12022-08-012023-07-3109688227ns10:PrivateLimitedCompanyLtd2022-08-012023-07-3109688227ns10:SmallEntities2022-08-012023-07-3109688227ns10:AuditExempt-NoAccountantsReport2022-08-012023-07-3109688227ns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3109688227ns10:SmallCompaniesRegimeForAccounts2022-08-012023-07-3109688227ns10:FullAccounts2022-08-012023-07-3109688227ns10:Director22022-08-012023-07-3109688227ns10:RegisteredOffice2022-08-012023-07-3109688227ns5:CurrentFinancialInstruments2023-07-3109688227ns5:CurrentFinancialInstruments2022-07-3109688227ns5:Non-currentFinancialInstruments2023-07-3109688227ns5:Non-currentFinancialInstruments2022-07-3109688227ns5:ShareCapital2023-07-3109688227ns5:ShareCapital2022-07-3109688227ns5:RetainedEarningsAccumulatedLosses2023-07-3109688227ns5:RetainedEarningsAccumulatedLosses2022-07-3109688227ns5:PlantMachinery2022-08-012023-07-3109688227ns5:PlantMachinery2022-07-3109688227ns5:PlantMachinery2023-07-3109688227ns5:PlantMachinery2022-07-3109688227ns5:CostValuation2022-07-3109688227ns5:CostValuation2023-07-3109688227ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-07-3109688227ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-07-31
REGISTERED NUMBER: 09688227 (England and Wales)















Unaudited Financial Statements

for the Year Ended 31 July 2023

for

Dermatology London Ltd

Dermatology London Ltd (Registered number: 09688227)






Contents of the Financial Statements
for the Year Ended 31 July 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Dermatology London Ltd

Company Information
for the Year Ended 31 July 2023







DIRECTORS: Dr N A Alam
Dr A L Starck





REGISTERED OFFICE: 7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP





REGISTERED NUMBER: 09688227 (England and Wales)





ACCOUNTANTS: Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP

Dermatology London Ltd (Registered number: 09688227)

Balance Sheet
31 July 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 25,984 2,973
Investments 5 21,334 13,445
47,318 16,418

CURRENT ASSETS
Debtors 6 53,819 23,149
Cash at bank 179,719 99,255
233,538 122,404
CREDITORS
Amounts falling due within one
year

7

110,175

73,798
NET CURRENT ASSETS 123,363 48,606
TOTAL ASSETS LESS CURRENT
LIABILITIES

170,681

65,024

CREDITORS
Amounts falling due after more
than one year

8

50,000

50,000
NET ASSETS 120,681 15,024

Dermatology London Ltd (Registered number: 09688227)

Balance Sheet - continued
31 July 2023

2023 2022
Notes £    £    £    £   
CAPITAL AND RESERVES
Called up share capital 104 104
Retained earnings 120,577 14,920
SHAREHOLDERS' FUNDS 120,681 15,024

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 March 2024 and were signed on its behalf by:





Dr N A Alam - Director


Dermatology London Ltd (Registered number: 09688227)

Notes to the Financial Statements
for the Year Ended 31 July 2023

1. STATUTORY INFORMATION

Dermatology London Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents trading income accrued during the period shown by these financial statements.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% Straight Line

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Dermatology London Ltd (Registered number: 09688227)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2022 - 5 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 August 2022 6,739
Additions 31,672
At 31 July 2023 38,411
DEPRECIATION
At 1 August 2022 3,766
Charge for year 8,661
At 31 July 2023 12,427
NET BOOK VALUE
At 31 July 2023 25,984
At 31 July 2022 2,973

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 August 2022 13,445
Share of profit/(loss) 7,889
At 31 July 2023 21,334
NET BOOK VALUE
At 31 July 2023 21,334
At 31 July 2022 13,445

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 53,819 23,149

Dermatology London Ltd (Registered number: 09688227)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 1 -
Taxation and social security 107,145 65,965
Other creditors 3,029 7,833
110,175 73,798

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
2023 2022
£    £   
Other creditors 50,000 50,000

Amounts falling due in more than five years:

Repayable by instalments
Other loans more 5yrs instal 50,000 50,000